• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CFTR 表达在急性胰腺炎中的定位错误和 VX-661+VX-770 治疗对疾病严重程度的有益作用。

Mislocalization of CFTR expression in acute pancreatitis and the beneficial effect of VX-661 + VX-770 treatment on disease severity.

机构信息

Department of Pathophysiology, University of Szeged, Szeged, Hungary.

First Department of Medicine, University of Szeged, Szeged, Hungary.

出版信息

J Physiol. 2021 Nov;599(22):4955-4971. doi: 10.1113/JP281765. Epub 2021 Oct 21.

DOI:10.1113/JP281765
PMID:34587656
Abstract

Cystic fibrosis transmembrane conductance regulator (CFTR) has an essential role in maintaining pancreatic ductal function. Impaired CFTR function can trigger acute pancreatitis (AP) and exacerbate disease severity. We aimed to investigate the localization and expression of CFTR during AP, and determined the effects of a CFTR corrector (VX-661) and potentiator (VX-770) on disease severity. AP was induced in FVB/n mice by 6-10 hourly intraperitoneal injections of 50 μg/kg cerulein. Some mice were pre-treated with five to six daily injections of 2 mg/kg VX-661 + VX-770. Control animals were administered physiological saline instead of cerulein and dimethyl sulfoxide instead of VX compounds. AP severity was determined by measuring laboratory and histological parameters; CFTR and CK19 expression was measured. Activity of ion transporters was followed by intracellular pH or fluid secretion measurement of isolated pancreatic intra-/interlobular ducts. Cerulein-induced AP severity was greatest between 12 and 24 h. CFTR mRNA expression was significantly increased 24 h after AP induction. Immunohistochemistry demonstrated disturbed staining morphology of CFTR and CK19 proteins in AP. Mislocalization of CFTR protein was observed from 6 h, while expression increased at 24 h compared to control. Ductal HCO transport activity was significantly increased 6 h after AP induction. AP mice pre-treatment with VX-661 + VX-770 significantly reduced the extent of tissue damage by about 20-30%, but other parameters were unchanged. Interestingly, VX-661 + VX-770 in vitro administration significantly increased the fluid secretion of ducts derived from AP animals. This study described the course of the CFTR expression and mislocalization in cerulein-induced AP. Our results suggest that the beneficial effects of CFTR correctors and potentiators should be further investigated in AP. KEY POINTS: Cystic fibrosis transmembrane conductance regulator (CFTR) is an important ion channel in epithelial cells. Its malfunction has several serious consequences, like developing or aggravating acute pancreatitis (AP). Here, the localization and expression of CFTR during cerulein-induced AP in mice were investigated and the effects of CFTR corrector (VX-661) and a potentiator (VX-770) on disease severity were determined. CFTR mRNA expression was significantly increased and mislocalization of CFTR protein was observed in AP compared to the control group. Interestingly, pre-treatment of AP mice with VX-661 + VX-770 significantly reduced the extent of pancreatic tissue damage by 20-30%. In vitro administration of VX-661 + VX-770 significantly increased the fluid secretion of ducts derived from AP animals. Based on these results, the utilization of CFTR correctors and potentiators should be further investigated in AP.

摘要

囊性纤维化跨膜电导调节因子(CFTR)在维持胰腺导管功能方面具有重要作用。CFTR 功能障碍可引发急性胰腺炎(AP)并加重疾病严重程度。我们旨在研究 CFTR 在 AP 期间的定位和表达,并确定 CFTR 校正剂(VX-661)和增强剂(VX-770)对疾病严重程度的影响。通过每隔 6-10 小时给 FVB/n 小鼠腹腔内注射 50μg/kg 蛙皮素诱导 AP。一些小鼠在 5-6 天内每天接受两次 2mg/kg VX-661+VX-770 的预处理。对照组动物给予生理盐水而不是蛙皮素,二甲基亚砜而不是 VX 化合物。通过测量实验室和组织学参数来确定 AP 的严重程度;测量 CFTR 和 CK19 的表达。通过测量分离的胰腺内/小叶间导管的细胞内 pH 或流体分泌来跟踪离子转运体的活性。蛙皮素诱导的 AP 严重程度在 12 至 24 小时之间最大。AP 诱导后 24 小时,CFTR mRNA 表达显著增加。免疫组织化学显示 AP 中 CFTR 和 CK19 蛋白的染色形态受到干扰。CFTR 蛋白的定位错误在 6 小时时就可以观察到,而与对照组相比,其表达在 24 小时时增加。AP 诱导后 6 小时,HCO3 转运活性显著增加。AP 小鼠用 VX-661+VX-770 预处理可使组织损伤程度降低约 20-30%,但其他参数不变。有趣的是,VX-661+VX-770 在体外给药可显著增加来自 AP 动物的导管的流体分泌。本研究描述了 CFTR 在蛙皮素诱导的 AP 中的表达和定位错误的过程。我们的结果表明,CFTR 校正剂和增强剂的有益作用应在 AP 中进一步研究。

关键点

囊性纤维化跨膜电导调节因子(CFTR)是上皮细胞中重要的离子通道。其功能障碍会导致多种严重后果,例如发展或加重急性胰腺炎(AP)。本研究旨在研究在鼠类中,蛙皮素诱导的 AP 期间 CFTR 的定位和表达,以及 CFTR 校正剂(VX-661)和增强剂(VX-770)对疾病严重程度的影响。与对照组相比,AP 中 CFTR mRNA 表达显著增加且 CFTR 蛋白定位错误。有趣的是,AP 小鼠用 VX-661+VX-770 预处理可使胰腺组织损伤程度降低约 20-30%。在体外给予 VX-661+VX-770 可显著增加来自 AP 动物的导管的流体分泌。基于这些结果,CFTR 校正剂和增强剂在 AP 中的应用应进一步研究。

相似文献

1
Mislocalization of CFTR expression in acute pancreatitis and the beneficial effect of VX-661 + VX-770 treatment on disease severity.CFTR 表达在急性胰腺炎中的定位错误和 VX-661+VX-770 治疗对疾病严重程度的有益作用。
J Physiol. 2021 Nov;599(22):4955-4971. doi: 10.1113/JP281765. Epub 2021 Oct 21.
2
VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.VX-445-泰泽卡托维瓦卡托联合治疗伴有一个或两个 Phe508del 等位基因的囊性纤维化患者。
N Engl J Med. 2018 Oct 25;379(17):1612-1620. doi: 10.1056/NEJMoa1807120. Epub 2018 Oct 18.
3
VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.VX-659-泰泽卡托维伐替卡与依伐卡托维在携带一个或两个 Phe508del 等位基因的囊性纤维化患者中的疗效。
N Engl J Med. 2018 Oct 25;379(17):1599-1611. doi: 10.1056/NEJMoa1807119. Epub 2018 Oct 18.
4
CFTR modulator therapy for cystic fibrosis caused by the rare c.3700A>G mutation.携带罕见 c.3700A>G 突变的囊性纤维化的 CFTR 调节剂治疗。
J Cyst Fibros. 2021 May;20(3):452-459. doi: 10.1016/j.jcf.2020.07.003. Epub 2020 Jul 14.
5
Physiological and pharmacological characterization of the N1303K mutant CFTR.N1303K 突变 CFTR 的生理和药理学特性。
J Cyst Fibros. 2018 Sep;17(5):573-581. doi: 10.1016/j.jcf.2018.05.011. Epub 2018 Jun 7.
6
Correctors and Potentiators Rescue Function of the Truncated W1282X-Cystic Fibrosis Transmembrane Regulator (CFTR) Translation Product.校正剂和增强剂挽救截短型W1282X-囊性纤维化跨膜传导调节因子(CFTR)翻译产物的功能。
J Biol Chem. 2017 Jan 20;292(3):771-785. doi: 10.1074/jbc.M116.764720. Epub 2016 Nov 28.
7
Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment.囊性纤维化跨膜电导调节因子修饰药物:囊性纤维化治疗的未来。
Ann Pharmacother. 2012 Jul-Aug;46(7-8):1065-75. doi: 10.1345/aph.1R076. Epub 2012 Jun 26.
8
Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination.三药复方(Trikafta)依利卓艾他康唑/艾美拉唑/卡博替尼(elexacaftor-tezacaftor-ivacaftor)对 F508del 及罕见 CFTR 突变体的别构折叠校正。
JCI Insight. 2020 Sep 17;5(18):139983. doi: 10.1172/jci.insight.139983.
9
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.在纯合子 F508del 突变的囊性纤维化患者中,elexacaftor 加 tezacaftor 加 ivacaftor 联合治疗方案的疗效和安全性:一项双盲、随机、3 期临床试验。
Lancet. 2019 Nov 23;394(10212):1940-1948. doi: 10.1016/S0140-6736(19)32597-8. Epub 2019 Oct 31.
10
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis.增效剂依伐卡托消除了囊性纤维化中ΔF508囊性纤维化跨膜传导调节因子的药理学校正作用。
Sci Transl Med. 2014 Jul 23;6(246):246ra96. doi: 10.1126/scitranslmed.3008680.

引用本文的文献

1
The function of chloride channels in digestive system disease (Review).氯离子通道在消化系统疾病中的作用(综述)
Int J Mol Med. 2025 Jun;55(6). doi: 10.3892/ijmm.2025.5540. Epub 2025 May 2.
2
The 12-Year Experience of the Hungarian Pancreatic Study Group.匈牙利胰腺研究小组的12年经验。
J Clin Med. 2025 Feb 18;14(4):1362. doi: 10.3390/jcm14041362.
3
Clinical significance of peripheral blood DDR1 and CtBP gene methylation detection in patients with acute pancreatitis.外周血 DDR1 和 CtBP 基因甲基化检测在急性胰腺炎患者中的临床意义。
Epigenetics. 2024 Dec;19(1):2421631. doi: 10.1080/15592294.2024.2421631. Epub 2024 Nov 1.
4
Human pancreatic ductal organoids with controlled polarity provide a novel ex vivo tool to study epithelial cell physiology.具有极性控制的人胰腺导管类器官为研究上皮细胞生理学提供了一种新的体外工具。
Cell Mol Life Sci. 2023 Jun 28;80(7):192. doi: 10.1007/s00018-023-04836-2.
5
Precision Medicine in Pancreatitis: The Future of Acute Pancreatitis Care.精准医学在胰腺炎中的应用:急性胰腺炎治疗的未来。
Function (Oxf). 2023 Apr 5;4(3):zqad015. doi: 10.1093/function/zqad015. eCollection 2023.
6
Bicarbonate Transport in Cystic Fibrosis and Pancreatitis.囊性纤维化和胰腺炎中的碳酸氢盐转运。
Cells. 2021 Dec 24;11(1):54. doi: 10.3390/cells11010054.